Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2005 2
2009 1
2010 1
2011 1
2013 1
2014 1
2016 2
2017 3
2020 3
2021 7
2022 3
2023 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

28 results

Results by year

Filters applied: . Clear all
Page 1
A Pronectin™ AXL-targeted first-in-class bispecific T cell engager (pAXLxCD3ε) for ovarian cancer.
Riillo C, Polerà N, Di Martino MT, Juli G, Hokanson CA, Odineca T, Signorelli S, Grillone K, Ascrizzi S, Mancuso A, Staropoli N, Caparello B, Cerra M, Nisticò G, Tagliaferri P, Crea R, Caracciolo D, Tassone P. Riillo C, et al. Among authors: crea r. J Transl Med. 2023 May 4;21(1):301. doi: 10.1186/s12967-023-04101-x. J Transl Med. 2023. PMID: 37143061 Free PMC article.
Treatment of Ligneous Conjunctivitis with Plasminogen Eyedrops.
Caputo R, Shapiro AD, Sartori MT, Leonardi A, Jeng BH, Nakar C, Di Pasquale I, Price FW Jr, Thukral N, Suffredini AL, Pino L, Crea R, Mathew P, Calcinai M. Caputo R, et al. Among authors: crea r. Ophthalmology. 2022 Aug;129(8):955-957. doi: 10.1016/j.ophtha.2022.03.019. Epub 2022 Mar 26. Ophthalmology. 2022. PMID: 35346720 No abstract available.
The First-In-Class Anti-AXL×CD3ε Pronectin™-Based Bispecific T-Cell Engager Is Active in Preclinical Models of Human Soft Tissue and Bone Sarcomas.
Polerà N, Mancuso A, Riillo C, Caracciolo D, Signorelli S, Grillone K, Ascrizzi S, Hokanson CA, Conforti F, Staropoli N, Gervasi L, Di Martino MT, Arbitrio M, Nisticò G, Crea R, Tagliaferri P, Juli G, Tassone P. Polerà N, et al. Among authors: crea r. Cancers (Basel). 2023 Mar 8;15(6):1647. doi: 10.3390/cancers15061647. Cancers (Basel). 2023. PMID: 36980534 Free PMC article.
Redox modulation of vitagenes via plant polyphenols and vitamin D: Novel insights for chemoprevention and therapeutic interventions based on organoid technology.
Scuto M, Trovato Salinaro A, Caligiuri I, Ontario ML, Greco V, Sciuto N, Crea R, Calabrese EJ, Rizzolio F, Canzonieri V, Calabrese V. Scuto M, et al. Among authors: crea r. Mech Ageing Dev. 2021 Oct;199:111551. doi: 10.1016/j.mad.2021.111551. Epub 2021 Aug 3. Mech Ageing Dev. 2021. PMID: 34358533 Review.
Wnt/β-Catenin Pathway in Experimental Model of Fibromyalgia: Role of Hidrox®.
D'Amico R, Cordaro M, Siracusa R, Impellizzeri D, Trovato Salinaro A, Scuto M, Ontario ML, Crea R, Cuzzocrea S, Di Paola R, Fusco R, Calabrese V. D'Amico R, et al. Among authors: crea r. Biomedicines. 2021 Nov 13;9(11):1683. doi: 10.3390/biomedicines9111683. Biomedicines. 2021. PMID: 34829912 Free PMC article.
Hidrox® and Endometriosis: Biochemical Evaluation of Oxidative Stress and Pain.
Cordaro M, Trovato Salinaro A, Siracusa R, D'Amico R, Impellizzeri D, Scuto M, Ontario ML, Interdonato L, Crea R, Fusco R, Cuzzocrea S, Di Paola R, Calabrese V. Cordaro M, et al. Among authors: crea r. Antioxidants (Basel). 2021 May 4;10(5):720. doi: 10.3390/antiox10050720. Antioxidants (Basel). 2021. PMID: 34064310 Free PMC article.
28 results